Physician profile
Craig E Wolff
NPI 1588633945
$1,110.39
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $721 · 2020: $290 · 2021: $66.74 · 2022: $32.64.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $336.11 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $190.15 | 2019 | |
| Janssen Pharmaceuticals, INC | $133.65 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $95.41 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $67.62 | 2019-2020 | |
| Inari Medical, INC. | $51.01 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $48.45 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $47.91 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $35.74 | 2019 | |
| Insmed, INC. | $27.86 | 2019 | |
| Genentech USA, INC. | $19.91 | 2019 | |
| Pfizer INC. | $14.34 | 2019 | |
| Grifols USA, LLC | $14.29 | 2020 | |
| Abbvie INC. | $13.50 | 2019 | |
| Amgen INC. | $11.94 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $2.50 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Wolff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.